/
Imagine a world where diseases like cancer and sepsis can be diagnosed early and monitored easily using routine blood tests. That s the world Volition is trying to build by developing its innovative family of simple, easy to use, cost-effective blood tests.
The business is unprofitable at the operating level (-1258.47% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 40.0% YoY with margins expanding 932.4pp.
Negative free cash flow of -$20M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
▲ +40.0% YoY
Net Income (TTM)
-$25M
▲ +13.4% YoY
Op. Margin
-874.50%
▲ +932.4pp YoY
ROIC
-219.55%
▲ +109.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$21M
▲ +24.4% YoY
Op. Cash Flow (TTM)
-$21M
▲ +24.0% YoY
Net Debt
$5M
Cash & Equiv.
$3M
5Y CAGR: +164.1%
Continue Research